The disappearance of CD4+ T cells during an HIV infection sets the stage for the characteristic immunodeficiency. But how do the virally infected cells protect themselves long enough to manufacture more HIV virions? A recent paper in Nature suggests that Nef may be part of the answer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Finkel, T. H. et al. Nature Med. 1, 129–134 (1995).
Geleziunas, R., Xu, W., Takeda, K., Ichijo, H. & Greene, W. C. Nature 410, 834–838 (2001).
Westendorp, M. O. et al. Nature 375, 497–500 (1995).
Gallo, R. C. Proc. Natl Acad. Sci. USA 96, 8324–8326. (1999).
Herbein, G. et al. Nature 395, 189–194 (1998).
Conti, L. et al. J. Immunol. 165, 3293–300 (2000).
Strack, P. R. et al. Proc. Natl Acad. Sci. USA 93, 9571–9576 (1996).
Deacon, N. J. et al. Science 270, 988–991 (1995).
Wang, J. K., Kiyokawa, E., Verdin, E. & Trono, D. Proc. Natl Acad. Sci. USA 97, 394–399 (2000).
Saksela, K., Cheng, G. & Baltimore, D. EMBO J. 14, 484–491 (1995).
Baur, A. S. et al. Immunity 1, 373–384 (1994).
Ross, T. M., Oran, A. E. & Cullen, B. R. Curr. Biol. 9, 613–621 (1999).
Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. & Baltimore, D. Nature 391, 397–401 (1998).
Swingler, S. et al. Nature Med. 5, 997–1103 (1999).
Xu, X. et al. J. Exp. Med. 189, 1489–1496 (1999).
Chun, T. W. et al. Nature Med. 6, 757–761 (2000).
Meinl, E., Fickenscher, H., Thome, M., Tschopp, J. & Fleckenstein, B. Immunol. Today 19 474–479 (1998).
Chang, H. Y., Yang, X. & Baltimore, D. Proc. Natl Acad. Sci. USA 96, 1252–1256 (1999).
Michaelson, J. S., Bader, D., Kuo, F., Kozak, C. & Leder, P. Genes Dev. 13 1918–1923 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xu, X., Screaton, G. HIV-1 Nef: negative effector of Fas?. Nat Immunol 2, 384–385 (2001). https://doi.org/10.1038/87682
Issue Date:
DOI: https://doi.org/10.1038/87682